Filling nozzle
The present invention provides a filling nozzle obtained by using a resin selected from a cycloolefin polymer and a cycloolefin copolymer, or a filling nozzle including a tubular passage for supplying a pharmaceutical solution, and a filling port disposed at a lower end of the tubular passage, in which the tubular passage and the filling port have a circular peripheral cross-section, and an inner diameter of the passage of the filling port is larger than an inner diameter of the tubular passage disposed on an upstream side.
1. A filling nozzle, comprising a nozzle body having a tubular passage for supplying a pharmaceutical solution, and a filling port having a passage formed continuously to a lower end of the tubular passage, for discharging the pharmaceutical solution from a tip of the filling port,
wherein an inner diameter of the tubular passage is 1.0 to 5.0 mm, and a length in the length direction of the filling nozzle is 10.0 to 300.0 mm, and
wherein the filling nozzle is formed by using a resin having a water contact angle of 80 to 94 degrees, and the resin is selected from the group consisting of a cycloolefin polymer, a cycloolefin copolymer, and polypropylene.
2. The filling nozzle according to claim 1 , wherein the inner diameter of the tubular passage is 1.0 to 3.0 mm.
3. The filling nozzle according to claim 1 , wherein the tubular passage has a constant inner diameter as a whole.
4. The filling nozzle according to claim 1 , wherein the resin is selected from a cycloolefin copolymer that is a copolymer of a cyclic olefin and an olefin, a cycloolefin ring-opening polymer, and a hydrogenated product of the cycloolefin ring-opening polymer.
5. The filling nozzle according to claim 1 , wherein the resin is an ethylene-norbornene copolymer.
6. The filling nozzle according to claim 5 , wherein the ethylene-norbornene copolymer contains a repeating structure derived from addition polymerization of norbornene.
7. The filling nozzle according to claim 1 , wherein the resin is selected from a norbornene ring-opening polymer that may be substituted with C1-6 alkyl, and a hydrogenated product of the ring-opening polymer.
8. A production method for a liquid pharmaceutical formulation, comprising filling a pharmaceutical solution in a vessel by using the filling nozzle according to claim 1 .
9. The production method according to claim 8 , wherein an active ingredient contained in the pharmaceutical solution is an antibody.